{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:23:27Z","timestamp":1787750607406,"version":"build-2784847793"},"reference-count":10,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>This systematic review and meta\u2010analysis aimed to assess the efficacy and safety of spironolactone for moderate to severe acne in adult women by synthesising data from randomised controlled trials (RCTs). The meta\u2010analysis demonstrated that spironolactone significantly increased the odds of treatment success, with a pooled odds ratio (OR) of 2.51 compared to placebo or doxycycline. This analysis supports spironolactone as a highly effective treatment for moderate to severe acne in adult women, particularly in hormonally driven cases. Its efficacy, combined with its role as an alternative to long\u2010term antibiotic therapy, makes it a valuable option for acne management in women population.<\/jats:p>","DOI":"10.1111\/ajd.14428","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T10:29:16Z","timestamp":1738837756000},"page":"165-168","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Spironolactone for the Treatment of Moderate to Severe Acne in Adult Women: A Systematic Review and Meta\u2010Analysis of Randomised Controlled Trials"],"prefix":"10.1111","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8186-2926","authenticated-orcid":false,"given":"Chia Siang","family":"Kow","sequence":"first","affiliation":[{"name":"International Medical University  Kuala Lumpur Malaysia"},{"name":"School of Applied Sciences University of Huddersfield  Huddersfield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5390-7026","authenticated-orcid":false,"given":"Dinesh Sangarran","family":"Ramachandram","sequence":"additional","affiliation":[{"name":"Monash University Malaysia  Bandar Sunway Selangor Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4058-2215","authenticated-orcid":false,"given":"Syed Shahzad","family":"Hasan","sequence":"additional","affiliation":[{"name":"School of Applied Sciences University of Huddersfield  Huddersfield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3754-1690","authenticated-orcid":false,"given":"Kaeshaelya","family":"Thiruchelvam","sequence":"additional","affiliation":[{"name":"International Medical University  Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S114830"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-97-1-52"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2016.12.002"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_11_6_1","unstructured":"Cochrane Methods Bias \u201cRoB 2: A Revised Cochrane Risk\u2010Of\u2010Bias Tool for Randomized Trials \u201d 2023 https:\/\/methods.cochrane.org\/bias\/resources\/rob\u20102\u2010revised\u2010cochrane\u2010risk\u2010bias\u2010tool\u2010randomized\u2010trials."},{"key":"e_1_2_11_7_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074349","article-title":"Effectiveness of Spironolactone for Women With Acne Vulgaris (SAFA) in England and Wales: Pragmatic, Multicentre, Phase 3, Double Blind, Randomised Controlled Trial","volume":"381","author":"Santer M.","year":"2023","journal-title":"BMJ"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v104.26002"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15559"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13518"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.p1114"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajd.14428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T05:27:05Z","timestamp":1746768425000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.14428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1111\/ajd.14428"],"URL":"https:\/\/doi.org\/10.1111\/ajd.14428","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"2024-09-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}